You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 9, September 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma

J. W. Harbour, P. E. Rubsamen and P. Palmberg
Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Fla.

OBJECTIVE: To determine the indications for and outcome of pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma. DESIGN: Retrospective review. SETTING: Tertiary referral ophthalmic hospital. PATIENTS: Twenty-two patients (24 eyes) who underwent pars plana vitrectomy in the management of malignant glaucoma. RESULTS: Fourteen eyes were phakic and 10 were pseudophakic at the initial vitrectomy. The primary indication for vitrectomy was failure of other therapies. In phakic eyes, the initial vitrectomy was successful in terminating malignant glaucoma without further surgery in 7 (100%) of 7 eyes that underwent lensectomy and in 5 (71%) of 7 eyes that not did not undergo lensectomy. The primary indication for lensectomy was corneal edema caused by lens-corneal touch. In pseudophakic eyes, the initial vitrectomy was successful in 9 (90%) of 10 eyes. Removal of the intraocular lens was performed in 1 eye. Perioperative complications included transient serous choroidal detachment in 2 eyes, transient exudative retinal detachment in 1 eye, and suprachoroidal hemorrhage in 1 eye. CONCLUSIONS: Pars plana vitrectomy is effective in treating phakic and pseudophakic malignant glaucoma. Success is contingent on establishing a pathway for aqueous flow into the anterior chamber, which usually is accompanied by intraoperative deepening of the anterior chamber. In phakic eyes, lensectomy may be considered for marked corneal edema, for dense cataract, or when the anterior chamber will not deepen during vitrectomy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Videoendoscope-Guided Fluorescein-Assisted Vitrectomy for Phakic Malignant Glaucoma
Chen et al.
Arch Ophthalmol 2005;123:1419-1421.
ABSTRACT | FULL TEXT  

Optical coherence tomography in malignant glaucoma following filtration surgery
Wirbelauer et al.
Br. J. Ophthalmol. 2003;87:952-955.
ABSTRACT | FULL TEXT  

Treatment of Malignant Glaucoma With Contact Transscleral Cyclophotocoagulation
Carassa et al.
Arch Ophthalmol 1999;117:688-691.
FULL TEXT  

Angle-closure Glaucoma Associated With Occult Annular Ciliary Body Detachment
Liebmann et al.
Arch Ophthalmol 1998;116:731-735.
ABSTRACT | FULL TEXT  

Options in the Management of Malignant Glaucoma
Johnson
Arch Ophthalmol 1998;116:799-800.
FULL TEXT  

Pars Plana Tube Insertion of Aqueous Shunt With Vitrectomy in Malignant Glaucoma
Azuara-Blanco et al.
Arch Ophthalmol 1998;116:808-810.
FULL TEXT  

Pars Plana Vitrectomy in the Treatment of Phakic and Pseudophakic Malignant Glaucoma
Cekic and Batman
Arch Ophthalmol 1998;116:118-118.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.